Patents by Inventor Joon Kyeong

Joon Kyeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine
    Patent number: 11986523
    Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: May 21, 2024
    Assignee: CELLTRION INC.
    Inventors: Joon Won Lee, Yeon Kyeong Shin, Hye Young Kang, Kwang Woo Kim, So Young Kim, Su Jung Kim, Jun Seok Oh, Won Yong Han
  • Method for Replicating Large-Area Holographic Optical Element, and Large Area Holographic Optical Element Replicated Thereby
    Publication number: 20240125996
    Abstract: A method for replicating a holographic optical element and a holographic optical element replicated thereby are provided. The holographic optical element is larger than a master. The master has a holographic grating pattern generated on the master by interference of the reflected, diffracted or transmitted beam generated by irradiating the master having a specific diffraction grating pattern formed thereon with a laser beam.
    Type: Application
    Filed: August 25, 2021
    Publication date: April 18, 2024
    Applicant: LG Chem, Ltd.
    Inventors: Bo Ra Jung, Joon Young Lee, Min Soo Song, Do Kyeong Kwon, Yeon Jae Yoo
  • Stable liquid pharmaceutical preparation
    Patent number: 11951207
    Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 9, 2024
    Assignee: Celltrion Inc.
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin
  • Magnesium based amorphous alloy having improved glass forming ability and ductility
    Publication number: 20050279427
    Abstract: Disclosed is a magnesium based amorphous alloy having a good glass forming ability and ductility. The Mg based amorphous alloy has a composition range of Mg100-x-yAxBy where x and y are respectively 2.5?x?30, 2.5?y?20 in atomic percent. Here, A includes at least one element selected from the group consisting of Cu, Ni, Zn, Al, Ag, and Pd, and B includes at least one element selected from the group consisting of Gd, Y, Ca, and Nd.
    Type: Application
    Filed: June 14, 2005
    Publication date: December 22, 2005
    Inventors: Eun Park, Men Hua, Do Kim, Hye Chang, Ju Lee, Joon Kyeong